Literature DB >> 12476972

Metvix (PhotoCure).

Kerstin Gardlo1, Thomas Ruzicka.   

Abstract

Metvix is a photosensitive cream containing the methyl ester of 5-aminolevulinic acid, which has been developed and launched by PhotoCure in Sweden for the treatment of high-risk basal cell carcinoma and actinic keratosis.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12476972

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN： 1472-4472


  3 in total

1.  Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.

Authors:  Lorena Rodriguez; Alcira Batlle; Gabriela Di Venosa; Sinan Battah; Paul Dobbin; Alexander J Macrobert; Adriana Casas
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

2.  Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.

Authors:  C M Perrett; J M McGregor; J Warwick; P Karran; I M Leigh; C M Proby; C A Harwood
Journal:  Br J Dermatol       Date:  2007-02       Impact factor: 9.302

3.  Quantitative approach to skin field cancerization using a nanoencapsulated photodynamic therapy agent: a pilot study.

Authors:  Simone K Passos; Paulo En de Souza; Priscila Kp Soares; Danglades Rm Eid; Fernando L Primo; Antonio Cláudio Tedesco; Zulmira Gm Lacava; Paulo C Morais
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.